Tissue Recovery

Where Recommendations are Based on Scientific Evidence  
Curr Mol Pharmacol. 2011 Jan 18. [Epub ahead of print]

Excess Exposure to Insulin is the Primary Cause of Insulin Resistance and its Associated Atherosclerosis.

Source

Division of Translational Biology, the Hamner Institutes for Health Sciences, Durham, NC 27709, USA. wcao@thehamner.org.

Abstract

The main goal of this review is to provide more specific targets for prevention and treatment of insulin resistance and associated atherosclerosis. Modern technologies and medicine have vastly improved human health and prolonged the average life span of humans primarily by eliminating various premature deaths and infectious diseases. The modern technologies have also provided us abundant food and convenient transportation tools such as cars. As a result, more people are becoming overfed and sedentary. People are generally ingesting more calories than their bodies' need, leading to the so-called "positive energy imbalance", which is inseparable from the development of insulin resistance and its associated atherosclerosis. A direct consequence of insulin resistance is hyperinsulinemia. The current general view is that insulin is not functional in the presence of insulin resistance. Thus, the role of insulin itself in the development of insulin resistance and associated atherosclerosis has not been recognized. We have recently observed that the basal level of insulin signaling is increased in the presence of insulin resistance and hyperinsulinemia. In this review, we will explain how the increased basal insulin signaling contributes to the development of insulin resistance and associated atherosclerosis. We will first explain how insulin causes insulin resistance through two arbitrary stages (before and after the presence of obvious insulin resistance), and, then, explain how the excess exposure to insulin and the relative insulin insufficiency contributes to the atherosclerotic diseases. We propose that blockade of the excess exposure to insulin is a viable approach to prevent and/or reverse insulin resistance and its associated atherosclerosis.

PMID: 21241239 [PubMed - as supplied by publisher]

 

 

 

The information on this website is provided for informational purposes only and is not intended as a substitute for the advice provided by your physician or other healthcare professional. The information and products on this website are not intended to diagnose, treat, cure or prevent any disease.